SCHEMBL29685367

SCHEMBL29685367

CNC(=O)c1ccc2ncc3c(c2c1)COC3

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IP6K1 Q92551 1/20 0.43
IP6K3 Q96PC2 1/20 0.43
IP6K2 Q9UHH9 1/20 0.43
PLK1 P53350 1/20 0.43
CCNC P24863 6/20 0.41
CDK8 P49336 6/20 0.41
CREBBP Q92793 1/20 0.39
TDP1 Q9NUW8 1/20 0.38
MAPK14 Q16539 1/20 0.37
THRB P10828 1/20 0.37
DYRK1B Q9Y463 1/20 0.37
HPGDS O60760 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
PIK3CD O00329 1/20 0.36
PIK3CA P42336 1/20 0.36
MTOR P42345 1/20 0.36
MET P08581 1/20 0.36
AXL P30530 1/20 0.36
MERTK Q12866 1/20 0.36
HTR2A P28223 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31712882 0.86 RET (0.44) IP6K1IP6K3IP6K2MAPK14HPGDS
SCHEMBL29685869 0.83 IP6K1 (0.39) IP6K1CCNCCDK8SMN1; SMN2
SCHEMBL26918319 0.83 IP6K1 (0.39) IP6K1CCNCCDK8SMN1; SMN2
SCHEMBL29875412 0.78 MAPK1 (0.38) MTORMET
SCHEMBL30615043 0.75 ROCK2 (0.42)
SCHEMBL31712852 0.72 IP6K1 (0.36) IP6K1CCNCCDK8SMN1; SMN2
SCHEMBL31187932 0.72 PTPN11 (0.49) CCNCCDK8CREBBPMAPK14DYRK1B
SCHEMBL31712866 0.70 CNR2 (0.36) HPGDSSMN1; SMN2
SCHEMBL19657529 0.68 PLK1 (0.57) IP6K1IP6K3IP6K2PLK1CCNC
SCHEMBL29875709 0.68 LCK (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4251624-A1 TRICYCLIC CARBOXAMIDE DERIVATIVES AS PRMT5 INHIBITORS Amgen, Inc (US) 2023-10-04 EP claimed
CN-116783191-A Tricyclic carboxamide derivatives as PRMT5 inhibitors 美国安进公司 2023-09-19 CN claimed
WO-2022115377-A1 TRICYCLIC CARBOXAMIDE DERIVATIVES AS PRMT5 INHIBITORS AMGEN INC. (US) 2022-06-02 WO claimed
CN-119855817-A Heterocyclic alkynyl-substituted amide derivatives, preparation method and application thereof 成都微芯药业有限公司 2025-04-18 CN disclosed
WO-2025026381-A1 HETEROCYCLYLALKYNYL SUBSTITUTED AMIDE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND USE THEREOF 成都微芯药业有限公司 2025-02-06 WO disclosed
EP-4288435-A1 TRICYCLIC-AMIDO-BICYCLIC PRMT5 INHIBITORS Amgen Inc. (US) 2023-12-13 EP disclosed
CN-117062816-A Tricyclic-amide-bicyclic PRMT5 inhibitors 美国安进公司 2023-11-14 CN disclosed
EP-4251624-A1 TRICYCLIC CARBOXAMIDE DERIVATIVES AS PRMT5 INHIBITORS Amgen, Inc (US) 2023-10-04 EP disclosed
CN-116783191-A Tricyclic carboxamide derivatives as PRMT5 inhibitors 美国安进公司 2023-09-19 CN disclosed
WO-2022169948-A1 TRICYCLIC-AMIDO-BICYCLIC PRMT5 INHIBITORS AMGEN INC. (US) 2022-08-11 WO disclosed
WO-2022115377-A1 TRICYCLIC CARBOXAMIDE DERIVATIVES AS PRMT5 INHIBITORS AMGEN INC. (US) 2022-06-02 WO disclosed